The name Botox has become shorthand for neurotoxin injectables that reduce the appearance of wrinkles and tighten the skin around your brow and eyes. Until now, all neurotoxin injectables have been similar to Botox in results and longevity. However, with Daxxify (short for DaxibotulinumtoxinA), the world finally receives a long-acting Botox that maintains its result longer.
DAXXIFY is an FDA-approved injectable cosmetic procedure used to treat moderate to severe glabellar lines. It serves as a substitute for Botox and is effective in both preventing and treating wrinkles that form between the eyebrows, with the added advantage of having a longer-lasting effect.
As of now, there are four primary neuromodulator products for cosmetic treatments — Xeomin, Jeuveau, Dysport, and Botox. While the specific formulations may vary, all of them are based on the active ingredient Botulinum Toxin Type A, which is why they act similarly. When injected into the upper face, they prevent communication between the targeted muscles and nerves, reducing movement and smoothing out the skin in the region. In most cases, the effects of Botulinum Toxin Type A last for up to four months before wearing off.
The investigational neuromodulator product DaxibotulinumtoxinA for Injection has the same primary ingredient — Botulinum Toxin Type A. However, Daxi is made with a proprietary peptide formulation and a highly-purified botulinum toxin without animal-based components. This formulation allows Daxi to work as a long-acting botox. According to clinical studies, the effects of Daxi last up to 24 weeks, which means you can maintain the results with only two treatments per year.
The primary benefit of Daxxify is that it has greater longevity than traditional Botox and other similar neuromodulator products. According to clinical studies, can take around 24 weeks for Daxi to start wearing off, and can take around 28 weeks for your face to return to its original condition. Patients opting for Daxxify neuromodulators will be able to retain the effects of their treatment with only two injections per year.
Like Botox, Daxxify will be used to treat the wrinkles and frown lines on the upper half of the face. As of now, Daxi is being studied for glabellar (frown) lines, forehead lines, and crow’s feet. The FDA has already approved Daxi for the treatment of frown lines. Revance expects that Daxxify will be approved for forehead lines and crow’s feet shortly.
With over 25 years of experience, Dr. Grover is one of the most experienced and reputable plastic surgeons in the industry. Before the procedure, Dr. Grover will talk to you about your expectations and use that insight to curate the ideal treatment plan for your specific needs. Dr. Grover also actively educates his patients to ensure they know what to expect.
If you have moderate to severe frown lines that you’d like reduced, you could be a good candidate for Daxxify. Ideal candidates should also be in generally good health, have realistic expectations for the procedure, and have no allergies to any of Daxxify’s ingredients.
Daxxify is generally considered to be a very safe treatment. In one large clinical study, there were no serious side effects caused by the treatment. Daxxify’s active ingredient, botulinum toxin type A, has been used in frown line treatments for more than two decades.
Daxxify can cause certain side effects, but most of them are minor. The most common side effects include:
In extremely rare cases, patients may experience more severe side effects. If you encounter any of the following symptoms after undergoing Daxxify treatment, you should seek immediate medical care:
Before your Daxxify treatment, Dr. Grover can apply a topical anesthetic to minimize any discomfort. You may feel a small pinch during the injections, but there shouldn’t be significant pain.
Most patients can see the results of Daxxify only one or two days after the treatment.
Yes. Studies have shown that Daxxify treatment can be effective with all skin types and tones.
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (949) 759 - 9551.
Get Started Send Us A Message